JUPITER Trial Emphasizes the Role of Oxidative Degeneration in Atherosclerosis
chrismasterjohnphd.substack.com
by Chris Masterjohn The most recent widely publicized trial using the cholesterol-lowering statin drugs, the JUPITER trial, has been enthusiastically hailed as a justification for the expansion of these expensive drugs from people with high cholesterol levels to those who have low-grade inflammation but normal cholesterol. The study hardly justifies this enthusiasm. It does, however, provide yet another confirmation that atherosclerosis is a disease of oxidative degeneration.
JUPITER Trial Emphasizes the Role of Oxidative Degeneration in Atherosclerosis
JUPITER Trial Emphasizes the Role of…
JUPITER Trial Emphasizes the Role of Oxidative Degeneration in Atherosclerosis
by Chris Masterjohn The most recent widely publicized trial using the cholesterol-lowering statin drugs, the JUPITER trial, has been enthusiastically hailed as a justification for the expansion of these expensive drugs from people with high cholesterol levels to those who have low-grade inflammation but normal cholesterol. The study hardly justifies this enthusiasm. It does, however, provide yet another confirmation that atherosclerosis is a disease of oxidative degeneration.